15
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10393 |
AT-007
|
Reductase | Endocrinology/Hormones; Metabolism |
AT-007 是口服有效的,中枢神经系统渗透性醛糖还原酶的高效抑制剂, IC50为 100 pM。在 GALT 缺失大鼠中,它降低了有毒的半乳糖醇水平并预防了疾病并发症。 | |||
T7949 |
NCC007
|
Casein Kinase | Metabolism; Stem Cells |
NCC007 是一种双酪蛋白激酶 Iα(CKIα)和 δ(CKIδ)抑制剂,IC50分别为 1.8 和 3.6 μM。它通过对 longdaysin 的 N9和 C2位进行结构修饰,可研究哺乳动物昼夜节律周期。 | |||
T8838 |
CCI-007
|
Apoptosis; Histone Methyltransferase | Apoptosis; Chromatin/Epigenetic |
CCI 007 是一种具有细胞毒性的选择性白血病抑制剂,在MLL 重排的敏感系婴幼儿白血病细胞中,IC50为2.5-6.2 μM。 | |||
T9010 |
IMM-H007
|
Others; AMPK | Chromatin/Epigenetic; Others; PI3K/Akt/mTOR signaling |
IMM-H007 是一种新型降脂剂,可增加 abca1 蛋白的表达。 | |||
T6842 |
G007-LK
|
PARP; Wnt/beta-catenin | Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Stem Cells |
G007-LK 是 TNKS1 和 TNKS2 的选择性抑制剂,IC50 分别为 46 nM 和 25 nM。 | |||
T67752 |
Compound V007-6018
|
Others | Others |
Compound V007-6018是一种类药化合物,用于药物筛选。 | |||
T37646 |
HB007
|
||
HB007 is a potent degrader of small ubiquitin-related modifier 1 (SUMO1). It mediates the ubiquitination and subsequent degradation of SUMO1, leading to a decrease in tumor growth in vivo. HB007 is a valuable tool for investigating brain, breast, colon, and lung cancers[1][2]. | |||
T38008 | KBC-007 | ||
KBC-007 is a synthetic branched chain-containing analog of α-galactosylceramide (α-GalCer). It induces IL-4 and IFN-γ secretion by mouse splenocytes when used at a concentration of 0.5 ng/ml and IL-2 secretion by DN32.D3 NKT hybridoma cells co-cultured with CD1d-transfected RBL cells pre-loaded with KBC-007 at a concentration of 8 ng/ml. KBC-007 (1 μg per animal) increases levels of IL-4, but not IFN-γ, to a similar degree as α-GalCer in mouse serum. KBC-007 (0.5 μg per animal) increases the sur... | |||
T71599 |
AqB007
|
||
AqB007 is a selective blocker of the Aquaporin-1 ion channel conductance, thereby slowing cancer cell migration. | |||
T70635 | ELND007 | ||
ELND007 is a Gamma secretase inhibitor. | |||
T74755 |
TUS-007
|
||
TUS-007是一种经蛋白酶体抑制剂修饰的CANDDY分子。尽管如此,TUS-007几乎不影响蛋白酶体活性。它是口服有效的KRASG12D/V降解剂,适用于KRAS G12D/V的无细胞化学敲除,并展现出抑制肿瘤的效果。【CANDDY:具亲和力及降解动力学的化学敲除】。 | |||
T131371 |
Compound N007-0023
|
||
Compound N007-0023 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T131371。 | |||
T131372 |
Compound N007-0014
|
||
Compound N007-0014 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T131372。 | |||
T131370 | Compound N007-0024 | ||
Compound N007-0024 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T131370。 | |||
T74380 |
XY-06-007
|
||
XY-06-007 是一种有效的选择性 B&H-PROTACBRD4BD1L94V 降解剂。XY-06-007 对BRD4BD1L94V 的DC50, 6 h 为 10 nM。XY-06-007 且具有适合的体内药代动力学特征。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73561 |
NK007
|
||
NK007 是一种新型抗 SARS-CoV-2 药物,其 EC50值为 30 nM。 |